- HX DAILY
- Posts
- HX RESEARCH - Weekly Review
Hello HX Research Reader,
We hope you enjoyed this last week of our research. Our goal is to give you market insight and actionable ideas to help make you money!
To read more about our story you can read our welcome message here.
We hope you got a chance to check out our content, but below is a summary in you case you missed anything…
HX Daily
Monday, September 30
CHINESE stocks just posted one of their biggest and fastest rallies EVER. We discuss the implications for American investors.
Tuesday, October 1
“Our Analysis of Visa Inc. (NYSE: V)”
Over the last 30 years, we have refined our research process into a few simple metrics. We use our “Quantamental” approach to look at Visa Inc. stock.
Wednesday, October 2
We share the TRADING wisdom of master trader Paul Tudor Jones. Jones has built one of the strongest track records in history over the last five decades.
Thursday, October 3
“The Past Predicts the Future”
“Past performance is not an indicative of future results.” This is the most common boilerplate on Wall Street, and we believe is 100% WRONG.
Friday, October 4
“Sam Bankman-Fried Version 2.0”
OpenAI CEO Sam Altman is Silicon Valley's newest royal family member. We discuss his complicated history and why it's important to investors like you.
HX Trader
Wednesday, October 2
Volume 1, Issue 36 - An Eye For Profits
The application of technology to healthcare is often referred to as “biotechnology.” This sector has produced some of the largest stock returns over the last few decades. We recommend shares of one of the leaders in the sector.
HX Income
Thursday, October 3
Volume 1, Issue 17 - Testing For Some Income
The expansion of the pharmaceutical industry has been one of the biggest advances in human history over the last half-century. Today's idea is one of these companies—a key service provider to the growth of the global pharmaceutical industry.
Reply